Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Dri Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

Healthcare Biotechnology
DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:DHT.UN)

DRI Healthcare Trust Reports First Quarter 2025 Results and Announces Internalization of Manager

Canada NewsWire 18 hours ago

DRI Healthcare Trust to Host First Quarter 2025 Earnings Call and Webcast on May 13, 2025

Canada NewsWire April 22, 2025

Quarterly Cash Distribution Payment Date Adjustment Due to Canadian Statutory Holiday

Canada NewsWire March 5, 2025

DRI Healthcare Trust Reports Fourth Quarter and Annual 2024 Results

Canada NewsWire March 3, 2025

DRI Healthcare Trust to Host Fourth Quarter and Full Year 2024 Earnings Call and Webcast on March 4, 2025

Canada NewsWire January 29, 2025

DRI Healthcare Trust Declares Special Unit Distribution

Canada NewsWire December 20, 2024

DRI Healthcare Trust Reports Third Quarter 2024 Results

Canada NewsWire November 6, 2024

DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat for the Treatment of Hereditary Angioedema Plus an Equity Investment in KalVista Pharmaceuticals

Canada NewsWire November 4, 2024

DRI Healthcare Trust Announces Upsized US$631.6 Million Credit Facilities

Canada NewsWire November 1, 2024
View More News ››

Opinion & Analysis (TSX:DHT.UN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:DHT.UN)

RE:RE:RBC

Yes, great call! Big pipeline, portfolio 'insulated' from potential tariffs, CEO taking 95% of comp in shares. Very positive...
HermannHaller - 1 hour ago

RE:RBC

Plus NCIB is back.  On earnings call, CEO said they will continue to weigh IRRs of new investment vs. buyback but that it's no...
SONOFFERGUS - 2 hours ago

RBC

May 12, 2025 DRI Healthcare Trust Q1/25 - Results mixed; Announces...
retiredcf - 3 hours ago

RE:RE:RE:RE:RE:RE:RE:T3 Error Update

Stock is recovering nicely, maybe that was the smell of money you were smelling. Haha
HermannHaller - 5 days ago

RE:RE:RE:RE:RE:RE:T3 Error Update

As the old saying goes, " One Shoe Dropped, When Will The Second Shoe Drop?", and there-in lies the problem imo. It appears...
raybay_98 - April 25, 2025

Analyst note

NBF reiterated $18 target today. Notes that the value of the current portfolio is C$13.50/unit, plus growth. Comp table shows RPRX at 9...
HermannHaller - April 24, 2025
View more Bullboard ››

Coppernico Metals Inc.

Coppernico Metals Inc.

Coppernico is a mineral exploration company focused on creating value for shareholders and stakeholders through diligent ...
View More »